Ishan Dyes and Chemicals Posts Q2 Turnaround Despite Auditor Concerns

Ishan Dyes and Chemicals reported a net profit of Rs 6.22 crore for the quarter ended September 30, 2026. The company recorded an inventory overstatement of Rs 8.99 crore, drawing a qualified conclusion from statutory auditors.

Reader Takeaway: Strong operational growth marks a return to profitability, yet unresolved inventory valuation issues persist as a major red flag.

What just happened

Ishan Dyes and Chemicals released its financial results for the quarter and half-year ended September 30, 2026. The company reported a significant operational turnaround with revenue climbing to Rs 20.37 crore from Rs 6.74 crore in the same quarter last year. Net profit for the period stood at Rs 6.22 crore compared to a loss of Rs 3.62 crore in Q2 FY26.

Why this matters

Despite the improved headline numbers, the company’s statutory auditors, M/s A R Sulakhe & Co, issued a qualified conclusion. The audit report highlights that finished goods inventory is valued above cost, which violates Ind AS 2 accounting standards. This overstatement artificially inflates equity by Rs 8.99 crore and implies that reported profit before tax would be lower by Rs 6.15 crore if corrected.

The backstory

This qualification is not a new development. The inventory valuation issue was previously flagged in the annual report for the year ended March 31, 2026, and again during the limited review for the quarter ended June 30, 2026. The company has yet to adjust its books to align with accounting standards, raising concerns about the reliability of the reported financial position.

Risks to watch

Investors should focus on the lack of corrective action by management. Persistent auditor qualifications suggest underlying issues in accounting transparency. Future earnings reports must be monitored for any adjustments to inventory values, as these could lead to downward revisions in profit and equity in subsequent quarters.

What to track next

Shareholders should track management commentary or future filings for a concrete timeline on when the inventory valuation will be reconciled with Ind AS 2 requirements.